See how our cervical cancer prevention program in Trinidad & Tobago, supported through PSI’s Maverick Collective, is partnering with the Ministry of Health to pilot new technologies for improved cervical cancer screening and bolstering national efforts to raise awareness of cervical cancer and the need for HPV vaccine and regular screening.
Non-communicable diseases (NCDs) were once considered to be challenges for affluent countries alone. But now, cardiovascular diseases, cancer, diabetes and other NCDs have emerged as the leading cause of death and disability worldwide, responsible for 41 million or 71% of all deaths annually.
The global burden of NCDs is increasing, and they disproportionately affect the developing world. In fact, more than 85% of premature deaths resulting from NCDs–those that occur from 30-69 years of age—occur in low- and middle-income countries and pose serious consequences for both individuals, families and communities. Since NCDs often strike during a person’s most productive years, they impede the broader economic development of these countries as well.
Tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets all increase the risk of death due to common NCDs. PSI focuses on moving our clients and providers across the spectrum of care for NCDs, from raising awareness to detection and management of diseases, with a focus on:
- Cervical cancer prevention through HPV vaccine promotion, early detection and treatment of cervical pre-cancers and referral for follow-on care
- Cardiovascular disease prevention through awareness, early detection and management of hypertension and type 2 diabetes
The Three Pillars of our Work in
In 2019, PSI's NCD programming reached over 880,000 users, including:
women across PSI's global network were screened for cervical cancer
people were screened for hypertension
people were screened for Type 2 Diabetes
Our NCD Solutions
In countries where cervical cancer rates are highest, informed access to contraception and HIV testing also remains a critical need. PSI systematically designs, tests and refines integrated sexual and reproductive health service delivery models to meet consumer needs, while improving health outcomes.
PSI liaises with manufacturers to identify new technologies for cervical cancer screening and pre-cancer treatment. We pilot technologies to understand their potential for both consumers and providers, to the impact for scale in low- and middle-income countries.
It is often challenging for consumers to maintain long-term hypertension treatment regimens. PSI explores ways to facilitate greater market presence and update of hypertension treatment protocols to include FDCs for the improvement of medication adherence.
Development assistance for health is shifting away from traditional, institutional donors to nontraditional sources. PSI has been at the forefront of cross-sector partnerships in global health; PSI’s NCD projects create successful partnerships with both corporate and philanthropic partners. PSI continues to innovate its partnership models to drive efficiency and impact.